Transdigm Group INC Form 4 insider transactions

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold a portion of his common stock holdings under a Rule 10b5-1 plan.

TransDigm Group Director W. Nicholas Howley exercised stock options and subsequently sold an equivalent number of shares for liquidity and diversification.

TransDigm Group INC's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold 3,000 shares of common stock on July 21, 2025, as part of a pre-arranged trading plan.

W. Nicholas Howley, a Director at TransDigm Group INC, executed a series of pre-planned transactions on July 15, 2025, involving the exercise of stock options and subsequent sale of common stock.

TransDigm Group INC's Co-Chief Operating Officer, Joel Reiss, significantly reduced his direct beneficial ownership by 3,000 shares on June 20, 2025, through a series of sales after exercising stock options.

TransDigm Group INC Director W. Nicholas Howley exercised stock options and subsequently sold a portion of the underlying common stock through a Rule 10b5-1 plan.

TransDigm Group Inc.'s Chief Financial Officer, Sarah Wynne, completed a pre-scheduled transaction on June 13, 2025, involving the exercise of stock options and the subsequent sale of common shares under a Rule 10b5-1 plan.

TransDigm Group INC Director Michael Graff reported a re-allocation of 1,000 common shares from direct ownership to family trusts, as disclosed in a recent SEC Form 4 filing.

TransDigm Group Inc. Director Robert J. Small reported the sale of 45,700 shares of common stock for approximately $65.1 million, executed under a Rule 10b5-1 trading plan.

TransDigm Group Inc.'s Chief Financial Officer, Sarah Wynne, reported the exercise of stock options and subsequent sale of common stock on June 12, 2025, under a pre-arranged 10b5-1 trading plan.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on May 20, 2025, according to a Form 4 filing.

Director Sean Hennessy exercised stock options and sold shares of TransDigm Group INC on May 20, 2025.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on May 15, 2025, according to a Form 4 filing with the SEC.

Director Michael Graff reports changes in beneficial ownership of TransDigm Group INC stock due to trust transactions.

Director Jorge L. Valladares III exercised stock options and sold shares of TransDigm Group INC through a family trust on May 13 and 14, 2025.

Jessica L. Warren, GC, CCO, and Secretary of TransDigm Group INC, reports the acquisition and disposal of common stock and stock options on May 13, 2025.

W. Nicholas Howley, a director at TransDigm Group INC, exercised stock options and sold shares on May 5, 2025, according to a recent SEC Form 4 filing.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on April 21, 2025, according to a Form 4 filing with the SEC.

TransDigm Group's CEO, Kevin Stein, exercised stock options and sold shares indirectly held through the Fortuna Trust under a pre-arranged 10b5-1 trading plan on April 14, 2025.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on April 15, 2025, according to a Form 4 filing.

Director David Barr acquired 35 shares of TransDigm Group INC common stock on March 26, 2025, in lieu of a semi-annual director fee.

Director Jane M. Cronin acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 26, 2025.

Director Sean P. Hennessy acquired 35 shares of TransDigm Group INC common stock in lieu of director fees on March 26, 2025.

Michele Santana, a director at TransDigm Group INC, acquired 27 shares of common stock in lieu of a semi-annual director fee on March 26, 2025.

Director Jorge L. Valladares III acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 26, 2025.

Director Michael Graff acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee.

Director Robert Small acquired 42 shares of TransDigm Group INC common stock in lieu of director fees on March 26, 2025.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on March 20, 2025, according to a Form 4 filing with the SEC.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on March 17, 2025, according to a recent SEC filing.

Robert Small, a director at TransDigm Group INC, reported the sale of common stock in multiple transactions on March 13th and 14th, 2025.